spacer
spacer

PDBsum entry 4yt7

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
4yt7

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
254 a.a.
57 a.a.
Ligands
4K1
SO4 ×4
GOL ×2
Metals
_CA
Waters ×248
PDB id:
4yt7
Name: Hydrolase/hydrolase inhibitor
Title: Factor viia in complex with the inhibitor 2-(2-{(r)-[(4- carbamimidoylphenyl)amino][5-ethoxy-2-fluoro-3-(propan-2-yloxy) phenyl]methyl}-1h-imidazol-4-yl)benzamide
Structure: Coagulation factor vii (heavy chain). Chain: h. Fragment: unp residues 213-466. Synonym: factor viia heavy chain, activated factor viia heavy chain, proconvertin, serum prothrombin conversion accelerator, spca. Engineered: yes. Coagulation factor vii (light chain). Chain: l. Fragment: unp residues 148-204.
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: f7. Expressed in: cricetinae. Expression_system_taxid: 10026. Expression_system_taxid: 10026
Resolution:
2.30Å     R-factor:   0.174     R-free:   0.198
Authors: A.Wei
Key ref: P.W.Glunz et al. (2015). Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors. Bioorg Med Chem Lett, 25, 2169-2173. PubMed id: 25881820 DOI: 10.1016/j.bmcl.2015.03.062
Date:
17-Mar-15     Release date:   29-Apr-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P08709  (FA7_HUMAN) -  Coagulation factor VII from Homo sapiens
Seq:
Struc:
466 a.a.
254 a.a.
Protein chain
Pfam   ArchSchema ?
P08709  (FA7_HUMAN) -  Coagulation factor VII from Homo sapiens
Seq:
Struc:
466 a.a.
57 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: Chains H, L: E.C.3.4.21.21  - coagulation factor VIIa.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Hydrolyzes one Arg-|-Ile bond in factor X to form factor Xa.

 

 
DOI no: 10.1016/j.bmcl.2015.03.062 Bioorg Med Chem Lett 25:2169-2173 (2015)
PubMed id: 25881820  
 
 
Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitors.
P.W.Glunz, X.Cheng, D.L.Cheney, C.A.Weigelt, A.Wei, J.M.Luettgen, P.C.Wong, R.R.Wexler, E.S.Priestley.
 
  ABSTRACT  
 
Heterocyclic amide isosteres were incorporated into a phenylglycine-based tissue factor/factor VIIa (TF-FVIIa) inhibitor chemotype, providing potent inhibitors. An X-ray co-crystal structure of phenylimidazole 19 suggested that an imidazole nitrogen atom effectively mimics an amide carbonyl, while the phenyl ring forms key hydrophobic interactions with the S1' pocket. Exploration of phenylimidazole substitution led to the discovery of potent, selective and efficacious inhibitors of TF-FVIIa.
 

 

spacer

spacer